Actively Recruiting
The Liver Care Trial
Led by Zealand University Hospital · Updated on 2023-05-17
408
Participants Needed
2
Research Sites
207 weeks
Total Duration
On this page
Sponsors
Z
Zealand University Hospital
Lead Sponsor
N
Novavi
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.
CONDITIONS
Official Title
The Liver Care Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Attending outpatient treatment for alcohol use disorder (ICD-10: F102 or F101) at Novavi Køge or Novavi Roskilde
- Provided informed written consent
You will not qualify if you...
- Not speaking Danish or English
- Known severe liver disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Novavi Køge
Køge, Denmark, 4600
Actively Recruiting
2
Novavi Roskilde
Roskilde, Denmark, 4000
Actively Recruiting
Research Team
P
Pernille Dahlin, MD
CONTACT
G
Gro Askgaard, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here